Does ALEMTUZUMAB Cause Progressive multifocal leukoencephalopathy? 147 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 147 reports of Progressive multifocal leukoencephalopathy have been filed in association with ALEMTUZUMAB (Campath). This represents 1.0% of all adverse event reports for ALEMTUZUMAB.
147
Reports of Progressive multifocal leukoencephalopathy with ALEMTUZUMAB
1.0%
of all ALEMTUZUMAB reports
47
Deaths
53
Hospitalizations
How Dangerous Is Progressive multifocal leukoencephalopathy From ALEMTUZUMAB?
Of the 147 reports, 47 (32.0%) resulted in death, 53 (36.1%) required hospitalization, and 7 (4.8%) were considered life-threatening.
Is Progressive multifocal leukoencephalopathy Listed in the Official Label?
Yes, Progressive multifocal leukoencephalopathy is listed as a known adverse reaction in the official FDA drug label for ALEMTUZUMAB.
What Other Side Effects Does ALEMTUZUMAB Cause?
Headache (1,808)
Fatigue (1,744)
Pyrexia (1,441)
Off label use (1,259)
Rash (1,094)
Nausea (1,053)
Dyspnoea (855)
Lymphocyte count decreased (852)
Asthenia (841)
Multiple sclerosis relapse (836)
What Other Drugs Cause Progressive multifocal leukoencephalopathy?
NATALIZUMAB (1,668)
RITUXIMAB (1,647)
CYCLOPHOSPHAMIDE (782)
PREDNISONE (606)
PREDNISOLONE (439)
TACROLIMUS (438)
METHOTREXATE (428)
DOXORUBICIN (421)
MYCOPHENOLATE MOFETIL (414)
VINCRISTINE (376)
Which ALEMTUZUMAB Alternatives Have Lower Progressive multifocal leukoencephalopathy Risk?
ALEMTUZUMAB vs ALENDRONATE
ALEMTUZUMAB vs ALENDRONATE\CHOLECALCIFEROL
ALEMTUZUMAB vs ALENDRONIC ACID
ALEMTUZUMAB vs ALEVE
ALEMTUZUMAB vs ALEVE CAPLET